课题基金 / 基金详情

Regulation of p53 and Checkpoint Signaling by Chromium(VI)

Regulation of p53 and Checkpoint Signaling by Chromium(VI)
Chromium(VI) 对 p53 和检查点信号传导的调节
批准号:
10306386
负责人:
Anatoly Zhitkovich
金额:
$36.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-01 至 2024-11-30

项目摘要

项目成果

Anatoly Zhitkovich的其他基金

相关文献

中文摘要
翻译
项目摘要 流行病学研究已确定六价铬[Cr(VI)]为人类致癌物 在不同国家的职业暴露人群中。这种有毒金属的存在 许多超级基金网站和许多州的饮用水也引起了公众的极大关注。 关于癌症和其他与环境接触有关的健康风险的健康问题, Cr(VI)。通过饮用水摄入Cr(VI), 小鼠小肠。将这些动物数据低剂量外推至环境风险, 人类需要了解Cr(VI)的致癌作用机制,这表明 使用特定的外推模型。Cr(VI)生成的Cr-DNA加合物最丰富 DNA损伤的形式,但这些加合物是弱的DNA扭曲,不诱导经典的DNA 损害反应。这个项目将调查一个假设上的一个主要作用的DNA修复产品 最初形成的Cr-DNA损伤在基因毒性应激的非典型分支的激活中 发信号。我们还将研究控制反应的生化过程, 应激敏感转录因子p53和Cr-DNA损伤的保护性G1检查点。的 这项工作的完成有望为不寻常的遗传特征提供机械解释 铬(VI)诱导的肺肿瘤和改善人类风险评估。
英文摘要
Project Summary Hexavalent chromium [Cr(VI)] is firmly established as a human carcinogen by epidemiological studies in occupationally exposed groups from different countries. The presence of this toxic metal at numerous Superfund sites and in drinking water across many states has also raised significant public health concerns regarding cancer and other health risks associated with environmental exposures to Cr(VI). Ingestion of Cr(VI) through drinking water produced clear evidence of carcinogenicity in the small intestine of mice. The low-dose extrapolation of these animal data to environmental risks in humans requires knowledge of the mechanism of the carcinogenic action for Cr(VI), which dictates the use of specific extrapolation models. Cr(VI) generates Cr-DNA adducts as the most abundant form of DNA damage but these adducts are weakly duplex-distorting and do not induce classic DNA damage responses. This project will investigate a hypothesis on a major role of DNA repair products of the initially formed Cr-DNA damage in the activation of noncanonical branches of genotoxic stress signaling. We will also examine the biochemical processes governing the responsiveness of the stress-sensitive transcription factor p53 and a protective G1 checkpoint to Cr-DNA damage. The completion of this work is expected to provide mechanistic explanations for unusual genetic features of Cr(VI)-induced lung tumors and improve human risk assessment.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
NAD+ metabolism controls growth inhibition by HIF1 in normoxia and determines differential sensitivity of normal and cancer cells.
NAD 代谢控制常氧条件下 HIF1 的生长抑制,并决定正常细胞和癌细胞的不同敏感性。
DOI: 10.1080/15384101.2021.1959988
发表时间: 2021
期刊: Cell cycle (Georgetown, Tex.)
影响因子: --
作者: [Luczak,MichalW, Krawic,Casey, Zhitkovich,Anatoly]
通讯作者: Zhitkovich,Anatoly
DOI: 10.1007/s00204-021-03167-0
发表时间: 2021-12
期刊: Archives of toxicology
影响因子: 6.1
作者: [Zhitkovich A]
通讯作者: Zhitkovich A
DOI: 10.1016/j.jbc.2023.105385
发表时间: 2023-12
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Krawic, Casey, Luczak, Michal W., Valiente, Sophia, Zhitkovich, Anatoly]
通讯作者: Zhitkovich, Anatoly
Chemical mechanisms of DNA damage by carcinogenic chromium(VI).
致癌性六价铬对 DNA 损伤的化学机制。
DOI: 10.1016/bs.apha.2022.07.003
发表时间: 2023
期刊: Advances in pharmacology (San Diego, Calif.)
影响因子: --
作者: [Krawic,Casey, Zhitkovich,Anatoly]
通讯作者: Zhitkovich,Anatoly
Nickel and toxic topoisomerase I products
  • 批准号:
    10542727
  • 项目类别:
  • 资助金额:
    $35.89万
  • 财政年份:
    2021
  • 负责人:
    Anatoly Zhitkovich
  • 依托单位:
Nickel and toxic topoisomerase I products
  • 批准号:
    10208065
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2021
  • 负责人:
    Anatoly Zhitkovich
  • 依托单位:
Nickel and toxic topoisomerase I products
  • 批准号:
    10374135
  • 项目类别:
  • 资助金额:
    $35.85万
  • 财政年份:
    2021
  • 负责人:
    Anatoly Zhitkovich
  • 依托单位:
Indirect Genotoxicity in Metal Carcinogenesis
  • 批准号:
    10527323
  • 项目类别:
  • 资助金额:
    $36.56万
  • 财政年份:
    2020
  • 负责人:
    Anatoly Zhitkovich
  • 依托单位: